The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn't Require Biological Sample of Patients, it Records Only Information Based on the Patients' Medical File.
Arcan database
1 other identifier
observational
13,000
1 country
1
Brief Summary
To identify the diagnostic and therapeutic approach (efficacy and toxicity) of patients with lymphoid malignant hemopathy who are managed in the hematology department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
February 26, 2019
CompletedFirst Posted
Study publicly available on registry
March 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 11, 2019
March 1, 2019
23 years
February 26, 2019
March 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Progression-free survival
Period between the end of the first treatment and the first confirmed relapse of lymphoma of patients who have received treatment to treat their lymphoma.
730 days
Study Arms (1)
Hematological diseases
Cohort of patients followed for lymphoid malignant hemopathy in Lyon Sud Hospital
Interventions
Data collection for biostatistical analysis about hematological diseases
Eligibility Criteria
Patients followed for lymphoid malignant hemopathy in Lyon Sud Hospital
You may qualify if:
- \- Patients followed for hematological diseases in Lyon Sud Hospital
You may not qualify if:
- \- Patients who doesn't have hematological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Lyon Sud
Pierre-Bénite, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gilles Salles, MD
Hospices Civils de Lyon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2019
First Posted
March 11, 2019
Study Start
January 1, 2003
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 11, 2019
Record last verified: 2019-03